DANIELLE THOMAS: Open Payments
NPI 1336839885 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 22 payments from 10 companies in 2025. Trend: 2023 $245 · 2024 $701 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $82 |
| Janssen Biotech, Inc. | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| UCB, Inc. | 2 | $50 |
| ABBVIE INC. | 2 | $47 |
| STRATA Skin Sciences, Inc. | 3 | $43 |
| Arcutis Biotherapeutics, Inc. | 2 | $42 |
| Galderma Laboratories, L.P. | 1 | $23 |
| GENZYME CORPORATION | 1 | $20 |
| Organon LLC | 1 | $8 |
Products named: OTEZLA, TREMFYA, COSENTYX, Bimzelx, SKYRIZI, XTRAC, Zoryve, AKLIEF.
Industry payments across MI — which companies pay providers there.
